Yahoo Finance

Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low ...

BEDFORD, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the peer-reviewed publication of data showing that AAVHSC16, one ...
Yahoo Finance

Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU

BEDFORD, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that it has completed a review of its business, and the Board of ...
Nasdaq

Homology Medicines Declares Distribution to Common Stockholders

This press release is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor ...
Seeking Alpha

Homology Medicines spikes on strategic review

Gene editing company Homology Medicines (NASDAQ:FIXX) added ~23% pre-market Friday after announcing that the company intends to evaluate strategic alternatives, including potential partnerships, a ...
GEN

One in a Million: Homology Medicines Targets New Approach for Rare Genetic Diseases

The field of human genetics is discovering disease-causing mutations at a rapid pace. These mutations drive thousands of rare, debilitating and fatal disorders. While some treatments are available to ...
GEN

Improving CRISPR-Cas9’s Rate of Homology-Directed Repair

In recent years, CRISPR-Cas9 genome editing has enjoyed spectacular success because it combines flexibility and usability. The Cas9 nuclease need only be loaded with a guide RNA to direct it to almost ...